New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease
Gerald Kleymann(Bayer (Germany)), Helga Rübsamen‐Waigmann(AiCuris (Germany)), Veniamin Pevzner(Bayer (Germany)), Oswald Lockhoff(Bayer (Germany)), Peter Eckenberg(Bayer (Germany)), Udo Schneider(Bayer (Germany)), Dieter Haebich, Ute Bach(Bayer (Germany)), Rüdiger Fischer(Bayer (Germany)), Guy Hewlett(Bayer (Germany)), Axel Jensen(Bayer (Germany)), Jörg Kolb(Bayer (Germany)), Jutta Mäben(Bayer (Germany)), Kerstin Henninger(Bayer (Germany)), Ulrich A. K. Betz(Bayer (Germany)), Wolfgang Bender(Valneva (Austria)), Andreas Popp(Bayer (Germany)), Olaf Weber, Judith Baumeister(Bayer (Germany)), Jörg Keldenich(Bayer (Germany)), Isabelle Frappa(Bayer (Germany)), Martin Hendrix(Bayer (Germany)), Gabriele Handke(Bayer (Germany))
Cited by 328
Related Papers
Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes
|Science|1993|776
Inhibition of Hepatitis B Virus Replication by Drug-Induced Depletion of Nucleocapsids
|Science|2003|506
Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer
|Oncogene|1997|326
Induction and down-regulation of PLK, a humanserine/threonine kinase expressed in proliferating cells andtumors.
|Proceedings of the National Academy of Sciences|1994|283
The antibiotic ADEP reprogrammes ClpP, switching it from a regulated to an uncontrolled protease
|EMBO Molecular Medicine|2009|230